Theratechnologies Inc T.TH

“Designated news release””

[palinc2000]

I dont have time to look for the definition in the Prospectus
Wino ? What are the consrquences ?

[realitycheck4u]

This post has been removed in accordance with Community Policy

[Wino115]

Good question. I assume the date, being one day after FY end was the first date they could talk about  changing the trial parameters (maybe board needed to approve first?), so the date makes a bit of sense. As for that wording, I am also only guessing and think it is probably something in the ATM where there could be certain news releases that are more "material" and allows the

[PWIB123]

Wino, is there any reason why they could'nt have had that conference call this morning?  Waiting 4-6 weeks to provide more clarity to the market is not an option in my opinion.

[Wino115]

Given most of the analysts wrote up notes it seems they are doing the fairly traditional approach of using those as the loud speaker on what they are saying, so in essence that is their "call" and how they are disseminating and discussing it via those analysts and what may seep in to the news.  So what those analysts are saying is what they heard and their interpretation. If I'

[muslix1]

National Bank on Theratechnologies Pausing TH 1902 Patient Enrollment, from 1 hour ago by MT Newswires 1 hour ago by MT Newswires   12:49 PM EST, 12/02/2022 (MT Newswires) -- Theratechnologies (TH.TO), which is down 32% at midday, announced that it is pausing patient enrollment in its oncology (TH1902) Phase 1 clinical trial on sortilin-expressing cancers as efficacy results to date

[PWIB123]

I would've preferred a conference call today laying out why they think the new approach is best, what they've seen in the trials to support that, and discussion around what next steps look like and the challenges from the old trial design. The details of budgets, new business plan, etc can come later. Maybe it wouldn't have helped much today, but they cannot wait and leave the markets

[JayjayUSA12007]

Quote:"I would've preferred a conference call today laying out why they think the new approach is best, what they've seen in the trials to support that, and discussion around what next steps look like and the challenges from the old trial design" Concur. Tha's precisely what Thera management needs to be. Should not be a coward after releasing this awful news by sticking